Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi:
10.1001/amajethics.2019.844.
Clarissa G. Barnes, Frederick L. Brancati, MD, MHS, and Tiffany L. Gary, PhD, MHS
To combat the rising incidence of type 2 diabetes, New York City requires laboratories with electronic reporting capacity to upload data on hemoglobin A1c measurements to a city department of health registry.
Distinguishing between elective and therapeutic abortions undermines the moral agency of patients and disproportionately amplifies moral rather than medical dimensions of the procedure.
AMA J Ethics. 2018;20(12):E1175-1180. doi:
10.1001/amajethics.2018.1175.
Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision.
AMA J Ethics. 2016;18(4):359-364. doi:
10.1001/journalofethics.2016.18.4.ecas1-1604.
Labels commonly used in clinical settings, like “elective” or “therapeutic,” influence how we think about the justifiability of abortion. We talk with Professor Katie Watson and Dr Maryl Sackeim about how the language clinicians use to describe abortion can affect patients’ experiences and even cause harm.
Editor in chief, Dr Audiey Kao, talks with Dr Matthew Wynia about allocation of critical care resources and clinicians' duty to show up to work during public health emergencies.
During one 2014 Ebola epidemic, arrival of “safe burial” teams was often delayed. Some buried their loved ones themselves, which undermined containment efforts.
AMA J Ethics. 2020;22(1):E5-9. doi:
10.1001/amajethics.2020.5.